https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Valdecilla Biobank collects a total of 2500 samples COVID-19

3 de June de 2020

On April 14, the National Network of Biobanks (RNBB) began incorporating human biological samples from patients with COVID-19 disease into biobanks to make them available to research projects. In just 5 weeks, it has registered nearly 62,000 samples, mainly serum, nasopharyngeal exudates, blood, plasma and leukocytes, as well as urine, faeces, nucleic acids or tissues, […]

Read more →

Reintegration of IDIVAL researchers

24 de May de 2020

In order to carry out the reinstatement of the researchers to their jobs, IDIVAL has held meetings with the researchers and with the Health and Safety Committee to initiate the de-escalation of some of its workers. In order to carry out a safe reinstatement of workers, general de-escalation rules have been developed, a general procedure […]

Read more →

Continuous partial epilepsy and cortical motor control

18 de May de 2020

Currently, there is still controversy as to what is the normal physiology of the motor system and control of voluntary movement in humans. Thus, most research and data come from animal experiments. Professor Fernández-Torre and his IDIVAL group have combined their experience in clinical practice in epilepsy and, in particular, in status epilepticus and their […]

Read more →

Telemedicine a key tool in the face of social distancing

11 de May de 2020

In August 2019, the INTENCIVE Project is launched, financed by the Interreg Europe program, whose main objective is to improve and implement electronic health programs and policies aimed at patients and healthcare professionals. Partners from five countries including the Southern Ostrobothnia Regional Council (Finland), the Seinäjoki University of Applied Sciences (Finland), the Pannon Business Network […]

Read more →

Analysis of the virulence of Pseudomonas aeruginosa

5 de May de 2020

P. aeruginosa is a bacterium that produces several life-threatening infections, especially in immunosuppressed patients, with cancer, burns, and cystic fibrosis, and is also one of the main causes of nosocomial infections. Coupled with the intrinsic resistance of this bacterium that makes it one of the most feared human pathogens, is its metabolic versatility and that […]

Read more →

Advances in the knowledge of the genetic architecture of the human cerebral cortex

31 de March de 2020

The journal Science has published the results of an international investigation that represents an important advance in the degree of knowledge about the genetic map that determines the structure of the key regions of the human cerebral cortex. These advances allow us to advance in knowing how genetic variability marks differences in the brain structure […]

Read more →

Serum transferrin is an independent predictor of mortality in severe alcoholic hepatitis

10 de March de 2020

Alcoholic hepatitis is a clinical picture that occurs when high amounts of alcohol are consumed in people who already have a regular consumption of it for a long time. It is an entity that in severe cases carries a very high mortality, in certain circumstances it reaches more than half of the cases in less […]

Read more →

Analysis of the BAFF cytokine as a biomarker potential

9 de March de 2020

The IDIVAL Transplant and Autoimmunity group, belonging to the Kidney Disease Research Network (REDINREN) funded by the ISCIII with FEDER funds, has published a recent work in its biomarker line of work associated with the clinical evolution of Renal Transplant. Renal transplantation is the best treatment for patients with advanced chronic kidney disease compared to […]

Read more →

Researchers at IDIVAL and CNIO find the molecular regulation that allows the skin to be continuously exposed to the sun

2 de March de 2020

The Cell Cycle, Determining Stem Cells and Cancer research group of the Valdecilla Health Research Institute (IDIVAL), led by Dr. Alberto Gandarillas, has just published a paper that includes the molecular regulation that makes it possible for epithelial cells such as skin epidermis do not die against continuous carcinogens such as sunlight. This discovery has […]

Read more →

Analysis of genotyping methodologies to detect RAS mutations

It is currently known that those patients with metastatic colorectal cancer (CCRm) whose tumors have mutations at the level of certain genes involved in the EGFR receptor pathway (HER-1), such as the RAS gene (KRAS or NRAS exons 2,3 and 4 ), do not benefit from therapy with monoclonal antibodies with antiEGFR activity (Cetuximab or […]

Read more →